Cathie Wood Doubled Down on This Biotech Stock, Should You?

Biotech company Ginkgo Bioworks’ (DNA) top-line growth didn’t translate into bottom-line improvement in its last quarter. The stock is currently trading approximately 84% below its 52-week high, and analysts expect the company to report significant losses in the fiscal 2022 and 2023. However, since renowned investor Cathie Wood has recently doubled down on DNA, should…

Companies Need To Be Better at Hiring, Not Firing. 7 Tips To Pick And Retain The Best Talent During Uncertain Economic Times.

Opinions expressed by Entrepreneur contributors are their own. Research by McKinsey and Company states it takes a “multifaceted approach to attract and retain talent” in the Great Resignation. Even as recession fears grow, 40% of workers plan to quit their jobs. So what are the most successful strategies for hiring and retaining talent amid the…

MarketBeat Podcast: Stock Market, Bad News is Good News

This week on The MarketBeat Podcast Kate’s guest is Michael Wang, founder of Prometheus Alternative Investments. Michael has done stints at Citigroup as well as hedge funds and understands the market from various perspectives. In this interview, he discusses why he believes institutional investors are positioned bearishly at this time, and how individuals should approach…

SPY vs. QQQ: Which ETF Wins in 2022?

Soon autumn leaves will do their best impression of this year’s U.S. stock market— a lot of falling. MarketBeat.com – MarketBeat Barring a miraculous late year run, the major indices will finish in the red for the first time since 2018. That means the ETFs that track them, will drag down many investment account values…